Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Pharmacies should expect FMD error messages for 'considerable' period

Pharmacists can expect to see “many” error messages “for a considerable period” as they scan medicines in line with EU anti-counterfeit legislation, C+D has learned.

The Falsified Medicines Directive (FMD) – which came into force on February 9 – requires all pharmacies to scan barcodes on medicines packaging at the point of dispensing.

However, the FMD is “currently in the ramp-up and stabilisation phase” and pharmacies should continue to expect error messages until all stakeholders – pharmacies, wholesalers, manufacturers, parallel distributors and software suppliers – adjust to the directive, Jerome Bertin, general manager at SecurMed, the non-profit organisation that manages the UK’s medicines verification systems, told C+D.

The Medicines and Healthcare products Regulatory Agency (MHRA) explained that one common error message occurs when pharmacies “try to scan 2D barcodes that do not relate to FMD safety features”.

SecurMed added: “A significant amount of non-FMD compliant packs still exist in the UK supply chain and will be dispensed before FMD-compliant medicines fully replace these.”

False alerts

The UK FMD Working Group for Community Pharmacy – which is managing the rollout – warned the day before the FMD came into force that “many ‘false positive’ alerts” were expected to be generated when pharmacy teams attempt to scan and decommission medicines.

The two most common error messages are “unknown product code” and “failed to find batch”, the group explained at the time. These are most likely to be caused by manufacturers not uploading relevant data to the system and do not necessarily indicate a falsified medicine.

When asked by C+D how false alerts can be differentiated from genuine alerts, Mr Bertin said SecurMed has a team that “continually reviews alerts” to determine which are false positives, before submitting them to the MHRA for investigation.

“The system does allow manufacturers to issue a recall [and] pharmacies scanning medicines that have been recalled would be automatically notified of this by the system,” he explained.

The MHRA said data and system suppliers are currently working to resolve “a small number of Europe-wide issues causing the problem” of false alerts, while it is working with stakeholder groups to create guidance for community pharmacies on managing the messages.

More than 10,000 pharmacies compliant

A total of 10,172 community pharmacies across the UK were FMD compliant as of July 5, according to SecurMed.

Raj Patel, chair of the UK FMD Working Group, said this shows community pharmacies’ “commitment to patient safety, even in light of Brexit and funding uncertainties”.

Has your pharmacy had any issues with its FMD system?

Related Content


Pharmacy Manager

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts